In March 2025, the company announced new options for the immediate-to-purchaser supplying of its Wegovy weight loss drug. The company recognized a fresh pharmacy, named NovoCare, which would charge clients $499 every month for entry to the drug, a lot less than 50 % the price of the drug as a result of other pharmaceutical distribution networks.[53